Dr. Karim Rasheed, MD

Dr. Rasheed practices at Sani Eye Surgery Center in Templeton, California.

Dr. Rasheed's NPI, 1750312088, was assigned on July 5, 2006. Dr. Rasheed graduated from Dow University of Health Sciences in 1985. Dr. Rasheed holds California license C43351.

Dr. Rasheed's primary practice is Sani Eye Surgery Center, at 1315 Las Tablas Rd, Templeton, CA 93465. The practice phone is (805) 434-2533.

Dr. Rasheed's primary practice is Sani Eye Surgery Center in Templeton, California. Dmand AI also links Dr. Rasheed to 1 medical group, named with a free account. Dr. Rasheed's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rasheed practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Rasheed's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Rasheed is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Rasheed's licenses on file in 2 states: California and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Rasheed treats.

CMS data shows 3,118 Medicare services from Dr. Rasheed across 14 procedure codes in 2024, for 569 Medicare patients. Medicare paid $207,834 for them.

CMS counts 569 Medicare patients who saw Dr. Rasheed in 2026. The largest group is 65 to 74, with 272 patients. 72% of them have high blood pressure, and 71% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rasheed's median patient age at 71, with 53% women.

In 2026, Dr. Rasheed wrote 1,948 Medicare Part D claims for 317 patients. 66% of them were for generic drugs. CMS names the drug for 1,890 of them, across 18 drugs with 11 or more claims each, at $78,723 in total drug cost. In 2023, CMS named 1,764 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rasheed for performance year 2026, reported as part of a group. Dr. Rasheed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 108 procedures of cataract surgery by Dr. Rasheed, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Rasheed. Dr. Rasheed's most frequent co-author is David Sarraf, MD.

CMS Open Payments shows 9 general payments to Dr. Rasheed from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Glaukos Corporation paid the most, $67.

Dmand AI lists 2 awards for Dr. Rasheed, most recently AAO Fellow in 2012.

Dr. Rasheed graduated from Dow University of Health Sciences in 1985. Dr. Rasheed is a member of AAO.

Dr. Rasheed is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.